Building Better BioTherapeutics Using Machine Learning And Synthetic Biology

In this webinar, ATUM’s Co-Founder and Chief Commercial Officer Dr. Claes Gustafsson's, breaks down ATUM's history with Machine Learning (ML) in Bio, as well as how they go about variable selection, searching the SQL space to find promoters, and finding antibodies. The presentation also covers ATUM's high throughput biologic automation and GMP master cell banking services.